WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), a science-based health care company improving patient care through neurotechnology, today announced that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, is scheduled to speak at the Canaccord Genuity Growth Conference at the Intercontinental Boston, Boston, MA on August 9, 2011. Dr. Gozani intends to provide an update on the Company’s business activities and on its new product NC-stat® DPNCheckTM for testing of systemic neuropathies such as diabetic peripheral neuropathy (DPN).
